Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016866
Filing Date
2025-05-14
Accepted
2025-05-14 16:31:21
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dyai20250331_10q.htm   iXBRL 10-Q 997884
2 EXHIBIT 31.1 ex_762963.htm EX-31.1 9527
3 EXHIBIT 31.2 ex_762964.htm EX-31.2 9399
4 EXHIBIT 32.1 ex_762965.htm EX-32.1 3801
5 EXHIBIT 32.2 ex_762966.htm EX-32.2 3789
11 logo.jpg GRAPHIC 8775
  Complete submission text file 0001437749-25-016866.txt   6301935

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dyai-20250331.xsd EX-101.SCH 49454
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dyai-20250331_cal.xml EX-101.CAL 39778
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20250331_def.xml EX-101.DEF 385082
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20250331_lab.xml EX-101.LAB 330568
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20250331_pre.xml EX-101.PRE 409507
63 EXTRACTED XBRL INSTANCE DOCUMENT dyai20250331_10q_htm.xml XML 1058101
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32513 | Film No.: 25946302
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)